Review: antipsychotic augmentation is effective for people with obsessive-convulsive disorder who are receiving, but not responding to, serotonin reuptake inhibitor monotherapy.
Dell'Osso
Bernardo
B
Department of Clinical Sciences "L Sacco", University of Milan, Milan, Italy.